HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bastien Joubert Selected Research

Leukocytosis (Pleocytosis)

5/2024Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABABR Antibodies.
10/2021Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bastien Joubert Research Topics

Disease

15Encephalitis (Encephalitis, Rasmussen)
04/2024 - 10/2015
15Neoplasms (Cancer)
03/2024 - 10/2015
13Autoimmune Diseases of the Nervous System
05/2024 - 10/2015
13Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
03/2024 - 01/2016
10Cerebellar Ataxia (Dysmetria)
03/2024 - 04/2016
8Glioma (Gliomas)
05/2024 - 11/2017
8Ataxia (Dyssynergia)
02/2023 - 04/2016
5Nervous System Diseases (Neurological Disorders)
01/2023 - 01/2020
4Seizures (Absence Seizure)
01/2023 - 01/2016
4Isaacs Syndrome (Neuromyotonia)
10/2022 - 01/2016
4Epilepsy (Aura)
09/2022 - 01/2019
4Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2018
3Central Nervous System Diseases (CNS Diseases)
04/2024 - 01/2022
3Nervous System Paraneoplastic Syndromes
01/2023 - 11/2019
3Myasthenia Gravis
03/2022 - 03/2017
3Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
01/2021 - 01/2018
3Thymoma (Thymic Carcinoma)
10/2020 - 01/2016
2Leukocytosis (Pleocytosis)
05/2024 - 10/2021
2Cognitive Dysfunction
05/2024 - 05/2018
2Brain Diseases (Brain Disorder)
03/2024 - 01/2018
2Melanoma (Melanoma, Malignant)
03/2024 - 01/2020
2Paraneoplastic Syndromes (Paraneoplastic Syndrome)
03/2024 - 01/2024
2Myositis (Idiopathic Inflammatory Myopathies)
03/2024 - 01/2018
2Mesothelioma
01/2024 - 11/2019
2Paraneoplastic Cerebellar Degeneration
02/2023 - 04/2016
2Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2023 - 01/2022
2Autoimmune limbic encephalitis
01/2023 - 10/2022
2Inflammation (Inflammations)
01/2022 - 08/2021
2Anterograde Amnesia
01/2022 - 01/2017
2Disease Progression
01/2022 - 05/2018
2Genetic Predisposition to Disease (Genetic Predisposition)
07/2021 - 07/2020
2Temporal Lobe Epilepsy
07/2021 - 07/2020
2Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 03/2017
1Neuromyelitis Optica (Devic's Disease)
04/2024
1Meningoencephalitis
03/2024
1Polyradiculoneuropathy (Polyradiculoneuritis)
03/2024
1Multiple Sclerosis
01/2024
1Vasculitis (Vasculitides)
01/2024
1Malignant Mesothelioma
01/2024
1Mononeuropathies (Mononeuritis Multiplex)
01/2024
1Carcinoma (Carcinomatosis)
02/2023
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2023
1Encephalomyelitis (Myeloencephalitis)
01/2023
1Movement Disorders (Movement Disorder)
01/2023
1Myoclonus (Nocturnal Myoclonus)
01/2023
1Pain (Aches)
01/2023
1Sleep Wake Disorders
01/2023
1Tremor (Tremors)
01/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023
1Neuromuscular Diseases (Neuromuscular Disease)
10/2022
1Drug Resistant Epilepsy
09/2022
1Meningitis
03/2022
1Lung Neoplasms (Lung Cancer)
03/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Memory Disorders (Memory Loss)
01/2022
1Neurosarcoidosis
01/2022
1Sarcoidosis (Schaumann Disease)
01/2022

Drug/Important Bio-Agent (IBA)

34AntibodiesIBA
05/2024 - 10/2015
14Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2015
13AutoantibodiesIBA
05/2023 - 10/2015
10Immune Checkpoint InhibitorsIBA
03/2024 - 11/2019
7Leucine (L-Leucine)FDA Link
05/2024 - 10/2020
5AntigensIBA
02/2023 - 01/2019
5Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2021 - 10/2019
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2024 - 01/2022
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3IpilimumabIBA
01/2024 - 11/2019
3NivolumabIBA
01/2024 - 01/2018
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2023 - 05/2018
2N-Methylaspartate (NMDA)IBA
05/2023 - 05/2018
2anti-leucine-rich glioma-inactivated 1 autoantibodyIBA
01/2023 - 09/2022
2Surface Antigens (Surface Antigen)IBA
08/2022 - 03/2017
2adenylate kinase 5IBA
10/2021 - 01/2017
2Netrin-1IBA
10/2020 - 03/2017
2SteroidsIBA
01/2020 - 01/2020
2Lomustine (CCNU)FDA Link
05/2018 - 11/2017
2Bevacizumab (Avastin)FDA Link
05/2018 - 11/2017
2Temozolomide (Temodar)FDA LinkGeneric
05/2018 - 11/2017
2Glutens (Glutelin)IBA
01/2018 - 04/2016
1gamma-Aminobutyric Acid (GABA)IBA
05/2024
1Myelin-Oligodendrocyte GlycoproteinIBA
04/2024
1Melanoma-Specific AntigensIBA
03/2024
1Immunoglobulin A (IgA)IBA
01/2024
1anti-Yo autoantibodiesIBA
02/2023
1anti-CASPR2 autoantibodyIBA
01/2023
1mesoglycanIBA
01/2023
1Programmed Cell Death 1 ReceptorIBA
03/2022
1LigandsIBA
03/2022
1EpitopesIBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Glial Fibrillary Acidic ProteinIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1ElementsIBA
01/2022
1AD 20 (AD-20)IBA
01/2022

Therapy/Procedure

7Immunotherapy
05/2024 - 01/2017
6Therapeutics
01/2024 - 01/2016
2Precision Medicine
01/2022 - 01/2019
2Drug Therapy (Chemotherapy)
05/2018 - 11/2017